CapsoVision CV
NASDAQ CV
$5.91 -0.21 (-3.43%)
At close: Aug 20, 2026 · 4:00 PM EDT

CapsoVision (CV) Other Working Capital Changes (2024 - 2025)

CapsoVision (CV) posted Other Working Capital Changes of -$91000.0 for Q4 2025, up 59.56% sequentially from -$225000.0 in Q3 2025, and down 138.72% YoY from $235000.0 in Q4 2024.

CapsoVision (CV) Other Working Capital Changes (2024 - 2025) Analysis & Trends

CapsoVision has reported Other Working Capital Changes for 2 years, with the latest figure at -$91000.0 in Q4 2025.

  • Quarterly Other Working Capital Changes fell 138.72% year-over-year to -$91000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$288000.0 (changed N/A YoY) and the FY2025 annual result came in at -$351000.0, down 1075.0% from the prior year.
  • Other Working Capital Changes rose to -$129000.0 in Q4 2025 per CV's latest filing, from -$636000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $323000.0 in Q4 2024 and troughed at -$636000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 CapsoVision 295.13 Mn 286.05 Mn 1.87 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -129,000.00
Dec 31, 2025 -129,000.00
Dec 31, 2025 -129,000.00
Sep 30, 2025 -636,000.00
Sep 30, 2025 -636,000.00
Sep 30, 2025 -636,000.00
Dec 31, 2024 323,000.00
Dec 31, 2024 323,000.00
Dec 31, 2024 323,000.00
Sep 30, 2024 -113,000.00
Sep 30, 2024 -113,000.00
Sep 30, 2024 -113,000.00